COVID-19 Pill - Molnupiravir: Efficacy and Safety Concerns

Explore the efficacy and safety concerns of Molnupiravir, an oral medication developed by Merck for mild to moderate COVID-19 cases, in this comprehensive 33-minute lecture. Delve into the drug's mechanism of action, pharmacology, intended population, and potential risks. Learn about the latest developments in COVID-19 treatment as Professor Zach Murphy presents detailed information supported by scientific references. Gain valuable insights into this innovative antiviral medication and its role in combating the ongoing pandemic.

Lab.
Molnupiravir Introduction.
Mechanism of Action (MOA).
Molnupiravir Pharmacology.
Population Targeted.
Efficacy.
Safety Concerns.
Comment, Like, SUBSCRIBE!.